ArticleDocumenta ophthalmologica. Advances in ophthalmology2002
Electro-ophthalmological recovery after withdrawal from vigabatrin.
Article in Documenta ophthalmologica. Advances in ophthalmology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 25 citations in OpenAlex.
- Electroretinographic (ERG) responses in pediatric patients using vigabatrin.Documenta ophthalmologica. Advances in ophthalmology · 2012Article
- Article
- Dose-related changes in retinal function and PKC-alpha expression in rabbits on vigabatrin medication. Effect of vigabatrin in the rabbit eye.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2009Article
- Full-field ERG and visual fields in patients 5 years after discontinuing vigabatrin therapy.Documenta ophthalmologica. Advances in ophthalmology · 2008Article
- Retinal function in rabbits does not improve 4-5 months after terminating treatment with vigabatrin.Documenta ophthalmologica. Advances in ophthalmology · 2006Article
- Changes in the electroretinogram resulting from discontinuation of vigabatrin in children.Documenta ophthalmologica. Advances in ophthalmology · 2003Article
- Vigabatrin Retinal Toxicity First Detected with Electroretinographic Changes: A Case Report.Journal of clinical & experimental ophthalmologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
unlabelledThis study describes the effects of stopping of the anti-epileptic drug vigabatrin on the visual field and electrophysiological changes in one third of the group of patients which is described in the paper 'Visual field and electrophysiological abnormalities due to vigabatrin' (Van der Torren and Graniewski, 2002). In 1997 several reports described the possible oculotoxic effect of vigabatrin followed by a reconsideration of this medication in epileptic patients. Vigabatrin was discontinued in one-third of the patients on chronic medication (mean duration 4.8 years). The visual field and electrophysiological examinations were repeated every 3 months if possible, otherwise at 6-month intervals. The EOG Arden index and the ERG rod b-wave showed a significant improvement when vigabatrin was discontinued. Repeated examinations of visual fields and electrophysiology shortly after discontinuation of the drug (between 1 and 3 months) and later on after 6 months and 1 year showed a recovery of the EOG Arden index and the ERG rod b-wave during this period. The visual fields did not change in either direction.
conclusionthe recovery effect is a strong argument for the hypothesis that the reduction in EOG and ERG b-wave is an oculotoxic effect. The electrophysiological improvement during 6 months or longer after discontinuation and the unchanged visual fields are an argument for the hypothesis that the visual field represents the irreversible intoxicating effect on the retina, whereas the electrophysiology represents a more direct effect on the retinal glial cells level.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.